Loss of estrogen receptor 1 enhances cervical cancer invasion

American Journal of Pathology

Volumn 177, Issue 2, 2010, Pages 884-895

  Zhai, Yali ^a   Bommer, Guido T ^a,b   Feng, Ying ^a   Wiese, Alexandra B ^a   Fearon, Eric R ^a   Cho, Kathleen R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; SHORT HAIRPIN RNA;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SCREENING; CELL INVASION; DOWN REGULATION; EMBRYO; ENZYME INHIBITION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR LIBRARY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER;

EID: 77957261402     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091166     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108
2. Ostor AG: Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993, 12:186-192
3. Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, Wilgus B, Yutzy W, Daniel R, Shah K, Peng S, Hung C, Roden R, Wu TC, Pardoll D: Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res 2005, 11:4717-4723
4. Wright TC, Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D: 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007, 197:340-345
5. Zhai Y, Kuick R, Nan B, Ota I, Weiss SJ, Trimble CL, Fearon ER, Cho KR: Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res 2007, 67:10163-10172
6. Kaur P, McDougall JK: HPV-18 immortalization of human keratinocytes. Virology 1989, 173:302-310
7. Garrett LR, Perez-Reyes N, Smith PP, McDougall JK: Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 1993, 14:329-332
8. De Geest K, Bergman CA, Turyk ME, Frank BS, Wilbanks GD: Differential response of cervical intraepithelial and cervical carcinoma cell lines to transforming growth factor-beta 1. Gynecol Oncol 1994, 55:376-385
9. De Geest K, Turyk ME, Hosken MI, Hudson JB, Laimins LA, Wilbanks GD: Growth and differentiation of human papillomavirus type 31b positive human cervical cell lines. Gynecol Oncol 1993, 49:303-310
10. Husnjak K, Grce M, Magdic L, Pavelic K: Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods 2000, 88:125-134
11. Kado S, Kawamata Y, Shino Y, Kasai T, Kubota K, Iwasaki H, Fukazawa I, Takano H, Nunoyama T, Mitsuhashi A, Sekiya S, Shirasawa H: Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynecol Oncol 2001, 81:47-52
12. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M: Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006, 44:2025-2031
13. Hajra KM, Chen DY, Fearon ER: The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62:1613-1618
14. Li LC, Dahiya R: MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431
15. Nonogaki H, Fujii S, Konishi I, Nanbu Y, Ozaki S, Ishikawa Y, Mori T: Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix. Cancer 1990, 66:2620-2627
16. Konishi I, Fujii S, Nonogaki H, Nanbu Y, Iwai T, Mori T: Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix. Cancer 1991, 68:1340-1350
17. Fonseca-Moutinho JA, Cruz E, Carvalho L, Prazeres HJ, de Lacerda MM, da Silva DP, Mota F, de Oliveira CF: Estrogen receptor, progesterone receptor, and bcl-2 are markers with prognostic significance in CIN III. Int J Gynecol Cancer 2004, 14:911-920
18. Ottaviano YL, Issa JP, Parl FF, Smith HS, Baylin SB, Davidson NE: Methylation of the estrogen receptor gene CPG island marks loss of estrogen in human breast cancer cells. Cancer Res 1994, 54:2552-2555
19. Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG, Davidson NE: Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 1998, 58:2515-2519
20. Muller HM, Widschwendter A, Fiegl H, Goebel G, Wiedemair A, Muller-Holzner E, Marth C, Widschwendter M: A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer. Cancer Lett 2004, 209:231-236
21. Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG: Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer 2006, 119:1908-1914
22. Hori M, Iwasaki M, Shimazaki J, Inagawa S, Itabashi M: Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases. Gynecol Oncol 2000, 76:89-96
23. Iwase H, Omoto Y, Iwata H, Toyama T, Hara Y, Ando Y, Ito Y, Fujii Y, Kobayashi S: DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers. Br J Cancer 1999, 80:1982-1986
24. Dhasarathy A, Kajita M, Wade PA: The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha. Mol Endocrinol 2007, 21:2907-2918
25. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM: EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 2003, 100:11606-11611
26. Ding L, Kleer CG: Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast. Cancer Res 2006, 66:9352-9355
27. Gonzalez ME, Li X, Toy K, DuPrie M, Ventura AC, Banerjee M, Ljungman M, Merajver SD, Kleer CG: Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. Oncogene 2009, 28:843-853
28. Holland D, Hoppe-Seyler K, Schuller B, Lohrey C, Maroldt J, Durst M, Hoppe-Seyler F: Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res 2008, 68:9964-9972
29. Maynadier M, Nirde P, Ramirez JM, Cathiard AM, Platet N, Chambon M, Garcia M: Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells. Adv Exp Med Biol 2008, 617:485-491
30. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H: Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin Cancer Res 2000, 6:512-518
31. Hu K, Zhong G, He F: Expression of estrogen receptors ERalpha and ERbeta in endometrial hyperplasia and adenocarcinoma. Int J Gynecol Cancer 2005, 15:537-541
32. Garcia M, Derocq D, Freiss G, Rochefort H: Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc Natl Acad Sci USA 1992, 89:11538-11542
33. Ali SH, O'Donnell AL, Mohamed S, Mousa S, Dandona P: Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors. Gynecol Oncol 2004, 95:637-645
34. Bandyopadhyay A, Wang L, Chin SH, Sun LZ: Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines. Neoplasia 2007, 9:113-118
35. Maminta ML, Molteni A, Rosen ST: Stable expression of the human estrogen receptor in HeLa cells by infection: effect of estrogen on cell proliferation and c-myc expression. Mol Cell Endocrinol 1991, 78:61-69
36. Platet N, Cathiard AM, Gleizes M, Garcia M: Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 2004, 51:55-67
37. Chung SH, Wiedmeyer K, Shai A, Korach KS, Lambert PF: Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer. Cancer Res 2008, 68:9928-9934
38. Parl FF: Multiple mechanisms of estrogen receptor gene repression contribute to ER-negative breast cancer. Pharmacogenomics J 2003, 3:251-253
39. Berger J, Daxenbichler G: DNA methylation of nuclear receptor genes-possible role in malignancy. J Steroid Biochem Mol Biol 2002, 80:1-11
40. Wentzensen N, Sherman ME, Schiffman M, Wang SS: Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 2009, 112:293-299
41. Henken FE, Wilting SM, Overmeer RM, van Rietschoten JG, Nygren AO, Errami A, Schouten JP, Meijer CJ, Snijders PJ, Steenbergen RD: Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer 2007, 97:1457-1464
42. Ahuja N, Issa JP: Aging, methylation and cancer. Histol Histopathol 2000, 15:835-842
43. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM: The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002, 419:624-629
44. Shi B, Liang J, Yang X, Wang Y, Zhao Y, Wu H, Sun L, Zhang Y, Chen Y, Li R, Zhang Y, Hong M, Shang Y: Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol 2007, 27:5105-5119
45. Bekkers RL, van der Avoort IA, Melchers WJ, Bulten J, de Wilde PC, Massuger LF: Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia. Eur J Gynaecol Oncol 2005, 26:376-382